The current state of oligometastatic and oligoprogressive non-small cell lung cancer

about

The current state of oligometastatic and oligoprogressive non-small cell lung cancer

Item

http://www.wikidata.org/entity/Q57172942

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

The current state of oligometastatic and oligoprogressive non-small cell lung cancer

@en

The current state of oligometastatic and oligoprogressive non-small cell lung cancer

@nl

type

Item

label

The current state of oligometastatic and oligoprogressive non-small cell lung cancer

@en

The current state of oligometastatic and oligoprogressive non-small cell lung cancer

@nl

prefLabel

The current state of oligometastatic and oligoprogressive non-small cell lung cancer

@en

The current state of oligometastatic and oligoprogressive non-small cell lung cancer

@nl

P1476

The current state of oligometastatic and oligoprogressive non-small cell lung cancer

@en

P2093

Puneeth Iyengar

http://www.w3.org/2001/XMLSchema#string

Vasu Tumati

http://www.w3.org/2001/XMLSchema#string

P2860

Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer

An individual patient data metaanalysis of outcomes and prognostic factors after treatment of oligometastatic non-small-cell lung cancer.

Stereotactic radiation therapy can safely and durably control sites of extra-central nervous system oligoprogressive disease in anaplastic lymphoma kinase-positive lung cancer patients receiving crizotinib.

Single agent maintenance therapy for advanced stage non-small cell lung cancer: a meta-analysis

Surgery for oligometastatic non-small cell lung cancer: long-term results from a single center experience.

Analysis of stage and clinical/prognostic factors for lung cancer from SEER registries: AJCC staging and collaborative stage data collection system.

Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two facto

A Phase I Dose-Escalation Trial of Single-Fraction Stereotactic Radiation Therapy for Liver Metastases

Local ablative therapy of oligoprogressive disease prolongs disease control by tyrosine kinase inhibitors in oncogene-addicted non-small-cell lung cancer.

Stereotactic body radiation therapy in multiple organ sites.

P304

S2537-S2544

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.21037/JTD.2018.07.19

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

Suppl 21

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30206497

http://www.w3.org/2001/XMLSchema#string

P932

6123193

http://www.w3.org/2001/XMLSchema#string